SPOTLIGHT -
Slideshow
Author(s):
Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.
Managing Catatonia: A Case Report From Rural South Africa
Treating ‘Morally Objectionable’ Patients
How the Study of Muscarinic Receptors Is Transforming Schizophrenia Treatment
What Will the Future of Alzheimer Disease Treatment Look Like?
Phase 1 Study Initiated: NBI-1140675 for Neurological and Neuropsychiatric Conditions
Presenting Our March Theme: Schizophrenia